INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

ZACKS INVESTMENT MANAGEMENT's Holding History (CIK: 0001086483)

Note: Option positions (PUT/CALL) are excluded.

Q2 2017
Shares 10,009 Value ($000) $1,212 Avg Close — Range —
Q4 2015
Shares 1,407 Value ($000) $210 Avg Close — Range —
Q3 2015
Shares 4,221 Value ($000) $700 Avg Close — Range —